摘要
目的探究拉贝洛尔联合硫酸镁对妊娠期高血压患者的治疗效果及妊娠结局影响。方法选取我院2017 年8 月—2019 年1 月收治的128 例妊娠期高血压孕妇作为主要研究目标,分为对照组和试验组。对照组患者接受单纯硫酸镁治疗方案,试验组患者接受硫酸镁+拉贝洛尔联合治疗方案。结果试验组患者治疗后收缩压、舒张压和平均动脉压低于对照组患者,试验组患者HCY 水平、HMGB1 水平以及CysC 水平均低于对照组患者,对照组患者不良妊娠结局率高于试验组患者。结论妊娠期高血压患者治疗中应用拉贝洛尔联合硫酸镁方案能有效改善患者的血压和血清指标,降低不良妊娠结局的发生风险。
Objective To investigate the effect of labetalol combined with magnesium sulfate on the treatment of pregnancy-induced hypertension and the effect of pregnancy outcome. Methods 128 pregnant women with gestational hypertension admitted to our hospital from August 2017 to January 2019 were selected as the main research targets, and divided into control group and experimental group. Patients in the control group received a single magnesium sulfate treatment regimen, and patients in the experimental group received a combination of magnesium sulfate and labetalol. Results The systolic blood pressure, diastolic blood pressure and mean arterial pressure were significantly lower in the experimental group than in the control group. The HCY level, HMGB1 level and CysC level were significantly lower in the experimental group than in the control group. Higher than the test group patients. Conclusion The application of labetalol combined with magnesium sulfate in the treatment of hypertensive patients with gestation can effectively improve the blood pressure and serum index of patients, and reduce the risk of adverse pregnancy outcomes.
作者
徐爱蓉
XU Airong(Department of Obstetrics and Gynecology, Anqiu People's Hospital, Weifang Shandong 262100, China)
出处
《中国卫生标准管理》
2019年第12期76-78,共3页
China Health Standard Management
关键词
妊娠期高血压
拉贝洛尔
硫酸镁
联合用药
妊娠结局
临床效果
hypertensive disorder complicating pregnancy
labetalol
magnesium sulfate
combination therapy
pregnancy outcome
clinical effect
